Edition:
India

Emmaus Life Sciences Inc (EMMA.OQ)

EMMA.OQ on NASDAQ Stock Exchange Capital Market

2.77USD
10 Sep 2019
Change (% chg)

$-1.72 (-38.31%)
Prev Close
$4.49
Open
$3.07
Day's High
$3.25
Day's Low
$2.49
Volume
469,090
Avg. Vol
22,242
52-wk High
$14.70
52-wk Low
$2.49

Summary

Name Age Since Current Position

Yutaka Niihara

59 2019 Chairman of the Board, Chief Executive Officer

Lan Tran

43 2019 President, Chief Administrative Officer

Willis Lee

58 2019 Vice Chairman of the Board, Chief Operating Officer

Joseph Sherwood

64 2019 Chief Financial Officer

Yasushi Nagasaki

51 2019 Senior Vice President - Finance

Robert Dickey

63 2019 Director

Masaharu Osato

64 2019 Director

Robin Smith

54 2019 Director

Wei Peu Zen

66 2019 Director

Ian Zwicker

71 2019 Director

Biographies

Name Description

Yutaka Niihara

Lan Tran

Willis Lee

Joseph Sherwood

Yasushi Nagasaki

Robert Dickey

Masaharu Osato

Robin Smith

Dr. Robin L. Smith, M.D, is Director of the Company. Dr. Robin L. Smith is a global thought leader in the regenerative medicine industry, one of the fastest growing segments of modern-day medicine. She received her M.D. from Yale University and an M.B.A. from the Wharton School of Business. During her tenure as CEO of the Caladrius Biosciences, Inc. (formerly NeoStem Inc.) (NASDAQ: CLBS), which she led from 2006 to 2015, she pioneered the company’s innovative business model, combining proprietary cell therapy development with a successful contract development and manufacturing organization. Dr. Smith raised over $200 million, completing six acquisitions and one divestiture while the company won an array of industry awards and business recognition including a first-place ranking in the Tri-State region (for two years in a row), and eleventh place nationally, on Deloitte’s Technology Fast 500™, and Frost & Sullivan’s North American Cell Therapeutics Technology Innovation Leadership Award.

Wei Peu Zen

Ian Zwicker